Ryan Specialty (RYAN)Director sold ~$226M

~$226M

Approx. value · 4.15M sh @ $54.50

Traded

Dec 5, 2025

Filed

Dec 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 2, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 8, 2025, the Board of Directors of Ryan Specialty Holdings, Inc. (the “Company” or “Ryan Specialty”) appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer of the Company to succeed Jeremiah Bickham as President, effective October 9, 2025.”
2. Oct 30, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
3. Dec 5, 2025 · this disclosureInsiderDirector sold ~$226M of RYAN shares in the open market

What came next

1. Dec 5, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 5, 2025, Ryan Specialty Holdings, Inc. (the “Company”) and Robert Le Blanc mutually agreed that Mr. Le Blanc would retire from the Board of Directors (the “Board”) of the Company effective as of February 11, 2026.”
2. Dec 12, 2025InsiderCEO sold ~$6.95M of RYAN shares in the open market
3. Feb 10, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results (and 2 more items)“On February 10, 2026, the board of directors of the Company (the "Board") approved a three-year restructuring program (the “Empower Program”), which will commence in the first quarter of 2026.”
4. Feb 20, 2026Insider · Their largest buy since 2024Director purchased ~$15K of RYAN shares in the open market
5. Feb 23, 2026Insider · 1 personInsiders: 2 purchases (~$1.0M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ryan Specialty

For Ryan Specialty, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 9 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RYAN page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Ryan Specialty

• SEC Form 4Sep 9, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 13, 2026

Everything OQRO holds on this company is on its RYAN page.